A Multicenter, Randomized, Placebo-Controlled, Double-Blinded Study of the Efficacy, Safety, and Pharmacokinetics of Cobiprostone for the Prevention of Severe Oral Mucositis in Subjects with Head and Neck Cancer (HNC) Receiving Concurrent Radiation and Chemotherapy (RT/CT)
Principal Investigator(s)
Email for information
Funded by
Geneva Foundation
Research Start Date
Status
Active
To evaluate the efficacy, safety, and pharmacokinetics (PK) of liquid cobiprostone in preventing oral mucositis, when administered topically to the oral mucosa via spray for the duration of radiation and chemotherapy(RT/CT).
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.